TAPESTRY PHARMACEUTICALS, INC.
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 21, 2017 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 555 Total Citation Count
- Sep 04, 1991 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9820962 9, 10-α, α-oh-taxane analogs and methods for production thereofJul 27, 16Nov 21, 17[A61K, C07D]
9802951 Biologically active taxane analogs and methods of treatment by oral administrationJul 25, 13Oct 31, 17[A61K, C07D]
9402824 9,10-α, α-OH-taxane analogs and methods for production thereofJan 23, 15Aug 02, 16[A61K, C07D]
8552056 Biologically active taxane analogs and methods of treatment by oral administrationSep 15, 12Oct 08, 13[A61K, C07D]
8273789 Biologically active taxane analogs and methods of treatment by oral administrationSep 01, 10Sep 25, 12[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0028,539 Biologically active taxane analogs and methods of treatmentAbandonedApr 09, 10Feb 03, 11[A61K, C07D, A61P]
2011/0009,480 Biologically active taxane analogs and methods of treatmentAbandonedApr 09, 10Jan 13, 11[A61K, C07D, A61P]
2009/0246,211 Molecular constructs suitable for targeted conjugatesAbandonedMay 11, 06Oct 01, 09[A61K, A61P, C07K]
2009/0156,828 Novel Compounds and Methods for Forming Taxanes and Using the SameAbandonedDec 21, 05Jun 18, 09[C07D]
2008/0269,319 Biologically active taxane analogs and methods of treatmentAbandonedJun 26, 08Oct 30, 08[A61K, C07D, A61P]
2008/0207,743 Biologically Active Taxane Analogs and Methods of TreatmentAbandonedFeb 28, 07Aug 28, 08[A61K, C07D, A61P]
2007/0225,510 Convergent Process for the Synthesis of Taxane DerivativesAbandonedMar 26, 07Sep 27, 07[C07D]
2006/0281,807 Quassinoid compositions for the treatment of cancer and other proliferative diseasesAbandonedJun 13, 05Dec 14, 06[A61K, C07D]
2005/0025,753 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cellsAbandonedApr 30, 04Feb 03, 05[A61K, C12N]
6825166 Molecular conjugates for use in treatment of cancerExpiredMar 25, 02Nov 30, 04[A61K, C07D, C07K]
2004/0175,722 Methods and compositions for reducing screening in oligonucleotide-directe-d nucleic acid sequence alterationAbandonedOct 07, 03Sep 09, 04[C12Q]
2002/0061,530 Enhanced targeting of DNA sequences by recombinase protein and single-stranded homologous DNA probes using DNA analog activationAbandonedJul 30, 01May 23, 02[C07H, C12Q, C12P, C07K]
6335164 Methods for targeting, enriching, detecting and/or isolating target nucleic acid sequence using RecA-like recombinaseExpiredMay 18, 99Jan 01, 02[C12Q]
5965361 In-situ hybridization method using RecA protein and RecA protein having marker or ligand for use in said methodExpiredOct 30, 95Oct 12, 99[C07H, C12Q, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
